This section and the four that follow present a complete, internally consistent financial model. The sponsor brief provides an explicit five-year outlook, revenue building from R180 million to R1.1 billion and the EBITDA margin from 8% to 25%, and an R700 million flagship investment. This model preserves the sponsor’s revenue and EBITDA margins exactly and independently derives every line below EBITDA: component depreciation of the building, equipment and platform base from commissioning; full cash interest on drawn debt; and 27% tax with assessed-loss carry-forward. It then builds a fundable, phased, multi-centre capital structure around them. The balance sheet is constructed to tie in every year, and the cash flow reconciles to the movement in cash.
Key performance indicators to monitor
Lenders and equity investors will track a defined set of indicators through the capital-intensive build. The dashboard below sets out the metrics, their purpose, and the modelled trajectory.
|
Indicator |
What it signals |
Modelled trajectory |
|---|---|---|
|
Centres open & beds |
Rollout progress |
1 → 5 centres; 120 → 600 beds |
|
Bed occupancy |
Utilisation & referral flow |
~62% → ~86% |
|
Therapists recruited |
The binding constraint |
Toward ~260, metros first |
|
EBITDA margin |
Operating leverage |
8% → 25% (sponsor outlook) |
|
DSCR |
Debt serviceability |
Below 1.0x in ramp — grace period required |
|
Net debt / EBITDA |
Leverage through the build |
Elevated early; falls as EBITDA scales |
|
Cash balance |
Liquidity through the build |
Positive on phased funding |
|
Multi-round funding |
The national vision |
Phased equity & development finance |
Financial performance at a glance
The dashboard below summarises the model’s headline outputs: a capital-intensive network that is loss-making through the early build (the J-curve) before scaling to the sponsor’s Year-5 targets as facilities fill and the network matures.
|
Metric |
Year 1 |
Year 3 |
Year 5 |
|---|---|---|---|
|
Revenue (R m) |
180 |
500 |
1,100 |
|
EBITDA (R m) |
14 |
100 |
275 |
|
EBITDA margin |
8% |
20% |
25% |
|
Net profit (R m) |
-36 |
-51 |
56 |
|
Centres open |
1 |
3 |
5 |
|
Beds |
120 |
360 |
600 |
|
DSCR (x) |
0.84x |
1.10x |
1.13x |
|
Net debt / EBITDA (x) |
9.68x |
3.61x |
2.57x |
Revenue by source at maturity
The revenue base is diversified across nine sources, anchored by institutional payers. The breakdown below applies the sponsor’s revenue mix to Year-5 revenue of R1.1 billion.
|
Revenue source |
Share |
Year-5 revenue (R m) |
|---|---|---|
|
Medical-aid payments |
40% |
440 |
|
Government contracts |
20% |
220 |
|
Private patients |
15% |
165 |
|
Home healthcare |
8% |
88 |
|
Corporate & occupational |
5% |
55 |
|
Equipment rental |
4% |
44 |
|
Training academy |
3% |
33 |
|
Research grants |
2% |
22 |
|
Donations & CSI |
3% |
33 |
|
Total |
100% |
1,100 |
Key modelling assumptions
|
Assumption |
Value |
Basis |
|---|---|---|
|
Centres (5-yr window) |
5 (of 10 in 10-yr vision) |
One new 120-bed centre per year |
|
Revenue outlook |
R180m → R1,100m |
Sponsor Table 3 (preserved) |
|
EBITDA margin |
8% → 25% |
Sponsor Table 3 (preserved) |
|
Bed occupancy |
~62% → ~86% |
Referral-driven ramp |
|
Depreciation |
Component, from commissioning |
Building 30yr; equipment 9yr; platform 5yr |
|
Flagship / 5-yr programme |
R700m / ~R2.0bn |
Flagship is Phase 1; network needs more |
|
Funding |
Equity R1.3bn / Debt R1.05bn |
~R2.35bn; phased, grace on principal |
|
Cost of debt |
11.5% |
Development / infrastructure finance |
|
Working capital |
~12% of revenue |
Medical-aid & government receivables |
|
Corporate tax / exit |
27% / 10.5x EV/EBITDA |
Loss carry-forward; healthcare-infra multiple |
Sources and uses
The immediate R700 million flagship investment and its use of funds are set out below, alongside the full five-year multi-centre funding picture that the plan ultimately requires.
|
Flagship (uses) |
R m |
5-yr programme (sources) |
R m |
|
|---|---|---|---|---|
|
120-bed flagship facility |
420 |
Equity (phased) |
1,300 |
|
|
Medical equipment |
110 |
Development / infra debt |
1,050 |
|
|
Digital systems |
35 |
Reinvested operating cash |
~(gap) |
|
|
Working capital |
85 |
|||
|
Marketing & launch |
15 |
|||
|
Staff recruitment & training |
35 |
|||
|
Total flagship |
700 |
Total external |
2,350 |
Analyst flagThe R700m funds the flagship — the programme needs ~R2bn, the vision far more
This is the single most important point in the financial plan. The R700 million launches the 120-bed flagship and the national platform; it does not fund the network. Building the five-centre network in the plan window requires roughly R2 billion of capital (about R1.3 billion of equity and R1.05 billion of development finance), and the full ten-year national vision runs to R4–5 billion or more. This is a phased, institutional-scale capital programme that depends on staged, milestone-linked funding rounds and, ideally, government and development-finance participation given the public-health benefit. Investors backing the flagship are funding proof-of-concept; the national vision must be underwritten as a multi-round programme from the outset.
Alignment with development-finance and impact mandates
The transaction is structured for a blend of equity, development finance, impact-health capital and government participation, and its features map directly onto their mandates. HarmonyBridge improves outcomes for medically fragile children, relieves pressure on the public acute-hospital system, expands access in under-served provinces, empowers caregivers, and creates over 1,000 skilled jobs while growing the scarce therapy workforce, core objectives for development-finance and impact investors and for provincial health departments. For commercial lenders, the purpose-built facilities and equipment provide asset security and the contracted institutional revenue provides visibility. The health-impact case and the financial case reinforce one another, which is what makes an otherwise capital-heavy plan financeable.
Healthcare-infrastructure peer economics — a reality check
South African healthcare-infrastructure operators discipline the plan’s assumptions. The acute hospital groups (Netcare, Life, Mediclinic) show that hospital infrastructure is capital-intensive, regulated and long-dated, trading at healthcare-infrastructure multiples, and that they, too, are specialist- and staff-constrained. HarmonyBridge’s dedicated paediatric transitional-care model is differentiated from all of them and creates a systemic benefit they value (freeing their acute beds), but it inherits the sector’s central lesson: capital and clinical capacity, not demand, are the constraints, and returns are moderate and patient.
|
Dimension |
Acute hospital groups |
Public rehab units |
HarmonyBridge |
|---|---|---|---|
|
Model |
Acute multi-specialty |
Limited rehab capacity |
Dedicated paediatric step-down |
|
Capital |
Very heavy |
Public-funded |
Heavy (R700m/flagship) |
|
Constraint |
Beds, staff, tariffs |
Funding & capacity |
Therapists & funding |
|
Relevance |
Partner, payer & multiple read |
Referral & need evidence |
First integrated national network |